Celenys Overview

  • Founded
  • 2013
Founded
  • Status
  • Out of Business
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Liquidation

Celenys General Information

Description

Developer of hyaluronic acid based scaffolds designed for 3D cell culture. The company's hyaluronic acid based scaffolds are based on 3D study model for oncology and stem cell culture.

Contact Information

Website
www.celenys.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 75 route de Lyons la forêt
  • 76000 Rouen
  • France
+33 09 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Celenys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 07-Mar-2017 00.000 Completed Bankruptcy: Liquidation
1. Early Stage VC 30-Apr-2014 00.000 00.000 Completed Generating Revenue/Not Profitable
To view Celenys’s complete valuation and funding history, request access »

Celenys Patents

Celenys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3023486-B1 Process for the chemical modification of polyetheramines, novel polyetheramines that can be obtained by this process, and the use of these polyetheramines Active 11-Jul-2014 00000000000
FR-3023486-A1 Process for the chemical modification of polyetheramines, novel polyetheramines that can be obtained by this process, and the use of these polyetheramines Granted 11-Jul-2014 00000000000
FR-3023485-B1 Method of modifying polysaccharides by grafting polyetheramines, polysaccharides so modified, and preparations comprising them and having rheological properties thermosensitive Active 11-Jul-2014 0000000000
FR-3023485-A1 Method of modifying polysaccharides by grafting polyetheramines, polysaccharides so modified, and preparations comprising them and having rheological properties thermosensitive Granted 11-Jul-2014 0000000000 0
US-20170204364-A1 Method for modifying polysaccharides by grafting polyetheramines, polysaccharides thus modified and preparations comprising same and having heat-sensitive rheological properties Abandoned 11-Jul-2014 C12N5/0043
To view Celenys’s complete patent history, request access »

Celenys Executive Team (3)

Name Title Board Seat Contact Info
Nicolas Dubois Co-Founder & Chief Executive Officer
Elise Demange Ph.D Co-Founder, President, Chief Scientific Officer and Chairman
Agathe Devaux Ph.D Director, Business Development
To view Celenys’s complete executive team members history, request access »

Celenys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial